![Angela Bagley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Angela Bagley
Directeur Technique/Scientifique/R&D chez
TREVENA, INC.
Profil
Angela Bagley is currently the Vice President-Technical Operations at Trevena, Inc. Prior to her current position, she held the role of Global Head-Pharmaceutical at Bristol Myers Squibb Co. She also served as the VP-Global Supply Chain Planning & Logistics at Celgene Corp.
and as the Head-Supply Chain & Process Engineering at Merck & Co., Inc. Ms. Bagley completed her undergraduate degree at North Carolina State University.
Postes actifs de Angela Bagley
| Sociétés | Poste | Début |
|---|---|---|
| TREVENA, INC. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Angela Bagley
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| CELGENE | Corporate Officer/Principal | - |
Formation de Angela Bagley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevena, Inc.
 Trevena, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development and commercialization of novel medicines for patients affected by central nervous system | Health Technology |
Choisissez Zonebourse 
